Identification of potential ATP-competitive cyclin-dependent kinase 1 inhibitors: De novo drug generation, molecular docking, and molecular dynamics simulation-Reference-Cited by-同舟云学术

Identification of potential ATP-competitive cyclin-dependent kinase 1 inhibitors: De novo drug generation, molecular docking, and molecular dynamics simulation

Published:2023-03 Issue: Volume:155 Page:106645
ISSN:0010-4825
Container-title:Computers in Biology and Medicine
language:en
Short-container-title:Computers in Biology and Medicine

Author:

He Fengming,Wang Xiumei,Wu Qiaoqiong,Liu Shunzhi,Cao Yin,Guo Xiaodan,Yin Sihang,Yin Na,Li Baicun,Fang Meijuan

Publisher

Elsevier BV

Subject

Health Informatics,Computer Science Applications

Reference73 articles.

1. Cyclin-dependent kinases;Malumbres;Genome Biol.,2014

2. Cell cycle regulation of DNA double-strand break end resection by Cdk1-dependent Dna2 phosphorylation;Chen;Nat. Struct. Mol. Biol.,2011

3. Role of cyclin-dependent kinase 1 in translational regulation in the M-phase;Kalous;Cells,2020

4. CDK1 structures reveal conserved and unique features of the essential cell cycle CDK;Brown;Nat. Commun.,2015

5. An overview of Cdk1-controlled targets and processes;Enserink;Cell Div.,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Potential Inhibitors of CDK1 by Integrating Pharmacophore-Based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation Studies, and Evaluation of Their Inhibitory Activity;ACS Omega;2024-09-13

2. Spectroscopic and computational studies of the biomolecular complex of chemotherapy drug, lomustine and a nucleotide base adenine;Spectroscopy Letters;2024-03-15

3. FIAMol-AB: A feature fusion and attention-based deep learning method for enhanced antibiotic discovery;Computers in Biology and Medicine;2024-01

4. Navigating the GSK-3β inhibitors as versatile multi-target drug ligands in Alzheimer’s disease intervention – A comprehensive review;Results in Chemistry;2024-01

5. Discovery of a urea-based hit compound as a novel inhibitor of transforming growth factor-β type 1 receptor: in silico and in vitro studies;Physical Chemistry Chemical Physics;2024